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To assess the impact of a clinical decision model for febrile children at risk for serious bacte-
rial infections (SBI) attending the emergency department (ED).
Methods
Randomized controlled trial with 439 febrile children, aged 1 month-16 years, attending the
pediatric ED of a Dutch university hospital during 2010-2012. Febrile children were random-
ly assigned to the intervention (clinical decision model; n=219) or the control group (usual
care; n=220). The clinical decision model included clinical symptoms, vital signs, and C-
reactive protein and provided high/low-risks for “pneumonia” and “other SBI”. Nurses were
guided by the intervention to initiate additional tests for high-risk children. The clinical deci-
sion model was evaluated by 1) area-under-the-receiver-operating-characteristic-curve
(AUC) to indicate discriminative ability and 2) feasibility, to measure nurses’ compliance to
model recommendations. Primary patient outcome was defined as correct SBI diagnoses.
Secondary process outcomes were defined as length of stay; diagnostic tests; antibiotic
treatment; hospital admission; revisits and medical costs.
Results
The decision model had good discriminative ability for both pneumonia (n=33; AUC 0.83
(95% CI 0.75-0.90)) and other SBI (n=22; AUC 0.81 (95% CI 0.72-0.90)). Compliance to
model recommendations was high (86%). No differences in correct SBI determination were
observed. Application of the clinical decision model resulted in less full-blood-counts (14%
vs. 22%, p-value<0.05) and more urine-dipstick testing (71% vs. 61%, p-value<0.05).
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Conclusions
In contrast to our expectations no substantial impact on patient outcome was perceived.
The clinical decision model preserved, however, good discriminatory ability to detect SBI,
achieved good compliance among nurses and resulted in a more standardized diagnostic
approach towards febrile children, with less full blood-counts and more rightfully urine-
dipstick testing.
Trial Registration
Nederlands Trial Register NTR2381
Introduction
Fever is one of the most common symptom among children presenting to the emergency de-
partment (ED) [1–3] and accountable for 10–20% of all acute admissions. [4–6] Fever may
have various causes, ranging from self-limiting viral infections to serious bacterial infections
(SBI) (e.g. septicemia, pneumonia, urinary tract infections). Febrile children at the ED pose a
diagnostic challenge, as physicians need to identify that relatively small proportion of SBI with
a potential fatal course, in this large group of children with self-limiting diseases.[7–9] To sup-
port physicians several guidelines and decision models have been developed focussing on im-
proving diagnosis, limiting diagnostic tests and improved cost-effectiveness. ([4, 7, 10–17]
However, the true impact of these diagnostic tools in clinical practice, taking the translation of
diagnostic risk predictions to clinical management recommendations and the subsequent com-
pliance of the clinicians with these recommendations into account, is hardly subject of re-
search. [18–20]
In this study we aimed to evaluate the impact of a previously developed clinical decision
model for febrile children in the daily practice of the ED. This model includes clinical signs,
symptoms and the biomarker C- reactive protein (CRP). [10] Results of this study will bridge
the often remaining gap in translating decision models into clinical practice.[19, 21, 22]
Methods
Study design and setting
We conducted a randomized controlled trial of a clinical decision model at the emergency de-
partment (ED) of the Erasmus MC-Sophia Children’s Hospital in Rotterdam, The Netherlands.
The protocol and CONSORT statement are available as supporting information; see S2 and S3
Files. This large inner-city university hospital is visited annually by nearly 9000 children with a
mixed ethnic population of which 90% involved basic pediatric care.[2] During the study peri-
od there was no national guideline available for handling febrile children at the ED, although
most physicians were familiar with the NICE febrile child guideline.[4]
Study population
We prospectively enrolled all consecutive pediatric patients (1 month—<16 years) present-
ing with fever at our ED from the first of September 2010 until June 30, 2012. Febrile children
were eligible if fever had been noted at home in the 24 hours prior to presentation, when body
temperature measured at the ED was38.5°C or fever was used as a positive discriminator of
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the Manchester Triage System (MTS).[23] From the major principle of reducing diagnostic un-
certainty by using a diagnostic decision model [5] we excluded well appearing febrile children
(no amber/red alarming signs)[4] with a clear focus of uncomplicated rhinitis/otitis and severe-
ly ill children (emergent triage category).[23, 24] Children with chronic co-morbidity were ex-
cluded because of their increased risk of having serious infections and developing a
complicated course.[25] Finally, children who reattended the ED within one week of their first
presentation were only included at their initial visit.
Study intervention
The intervention consisted of the implementation of the clinical decision model, based on a
polytomous logistic regression model of 2,717 febrile children who presented to the ED and in-
cluded eleven predictors of pneumonia and other SBI versus no SBI (Table 1)[10]. Instructions
on the use of the clinical decision model and the study process included individual briefings,
practice cases for emergency staff (nurses/physicians), information by email, and posters
mounted at the ED. During the trial period, feedback and periodic teaching sessions were orga-
nized. The clinical decision model presented patient-specific risk estimates (percentages) for
both pneumonia and other SBI, which were categorized in high- or low risk groups and conse-
quently were accompanied by recommendations for further diagnostic testing (Fig 1). These
recommendations and risk estimates were only presented for children allocated to the inter-
vention group; others were designated ‘usual care’ after completion of entering the model pre-
dictors (control group). Cut-off points for additional diagnostic testing were based on the
diagnostic performance of the original prediction model at different risk thresholds, and were
agreed upon by expert panel.[10] For the chosen cut-off points, the expected gain was maxi-
mized based on the ratio of false positive/negative errors and expected adverse consequences of
a delayed diagnosis SBI. For high-risk children, nurses were instructed to initiate additional
testing before physician’s assessment. This recommendation implied chest-radiography in chil-
dren with estimated risk for pneumonia15% and urine-dipstick and culture if estimated risk
for other SBI was30%. Following the local protocol [26] and international guidelines [27]
urine-dipstick testing was also recommended in low-risk children without a clear focus for
their febrile illness. Nurses and physicians were blinded for these cut-off values and for the con-
tribution of predictors on risk scores. Physicians were able to overrule the recommendations
by adding to or refraining from additional diagnostic testing. In the control group the physi-
cian first examined the patient and ordered diagnostic procedures according to their own judg-
ment, but with the knowledge of a CRP-value which was required to enable randomization.
Data collection
All children who attended the ED were routinely triaged with the Manchester Triage System
(MTS).[23, 24, 28, 29] After patient triage, model predictors were entered by the nurse for each
individual patient. We collected patient characteristics (e.g. gender, age, reason of ED visit), re-
ferral profile, duration of the febrile episode, clinical signs/symptoms, observations and mea-
sures from physical examination (e.g., vital signs, clinical appearance). Data on all performed
laboratory tests (e.g. full blood-count, CRP), additional diagnostic tests (e.g. chest-radiography,
urine-dipstick, blood/urine-culture) and treatment/follow-up were registered prospectively in
the computer-based hospital information system. The clinical decision model was imple-
mented as a stand-alone device, accessible from each computer at the ED. A central logbook re-
corded data from all entered participants (Fig 1). Completing all variables of the clinical
decision model was mandatory before randomization could be initiated. Once the risk estimate
was shown to the nurse, no changes could be made to the entered model predictors.[30] The
Impact Clinical Decision Model for Febrile Children in Emergency Care
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Table 1. Patient characteristics.
Intervention Usual care
(n = 219) (n = 220)
Decision model variables
Age (years)a 2.0 (1.0–4.2) 1.7 (0.8–3.9)
Sex, male* 140 (63.9) 145 (65.9)
Temperature a (°C) 38.9 (38.2–39.5) 38.9 (38.0–39.5)
Duration fevera (days) 2.0 (1.0–4.0) 2.0 (1.0–4.0)
Prolonged capillary refill* (>2 sec) 18 (8.2) 26 (11.8)
Chest wall retractions* 10 (4.6) 16 (7.3)
Ill appearance* 44 (20.1) 49 (22.3)
Saturation (<94% O2) * 3 (1.4) 4 (1.8)
Respiratory rate a (/minute) 28.0 (24.0–40.0) 32.0 (24.0–39.0)
Heart rate a (/minute) 135.0 (120.0–160.0) 140.0 (120.0–156.0)
CRP a (mg/L) 12.0 (8.0–39.0) 13.0 (7.0–35.8)
Referral to emergency department
Self-referral* 120 (54.8) 115 (52.3)
Primary care* 57 (26.0) 67 (30.5)
Ambulance* 21 (9.6) 17 (7.7)
Other*# 20 (9.1) 20 (9.1)
Missing* 1 (0.5) 1 (0.5)
MTS urgency
Urgent*^ 181 (82.6) 193 (87.7)
Non-urgent*^ 35 (16.0) 26 (11.8)
Missing* 3 (1.4) 1 (0.5)
Final diagnoses
Serious bacterial infections* 27 (12.3) 28 (12.7)
Sepsis* 1 (0.5) 1 (0.5)
Pneumonia* 19 (8.7) 14 (6.4)
Urinary tract infection* 5 (2.3) 9 (4.1)
Bacterial gastroenteritis* 1 (0.5) 1 (0.5)
Pulmonary tuberculosis) * 1 (0.5) -
Abscess* - 2 (0.9)
Scarlatina* - 1 (0.5)
Self-limiting/ viral diseases* 192 (87.7) 192 (87.3)
Upper respiratory tract infection 109 (49.8) 116 (52.7)
Lower respiratory tract infection 14 (6.4) 15 (6.8)
Gastroenteritis 20 (9.1) 18 (8.2)
Others^^ 49 (22.4) 43 (19.5)
* Absolute number (percentage).
a Median (25–75 percentiles).
# ‘Other’ includes secondary care and after telephone contact.
^ ‘Urgent’ includes very urgent/ urgent; ‘Non-urgent’ includes standard/ non-urgent.
^^ Others includes for example. Influenza, chicken-pox, stomatitis.
doi:10.1371/journal.pone.0127620.t001
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randomization mechanism, based on even/odd seconds indicated by the digital computer
clock, was unknown to nurses and physicians.
Ethics was obtained by the institutional review board (IRB) of the ErasmusMC. According
to IRB-review the intervention contained no additional risks as patients were not subjected to
additional operations and no rules of conduct were imposed. Written informed consent was re-
quired by IRB and it was obtained from all caretakers, or guardians on behalf of the children
enrolled (MEC-2008-071).
Outcome measures
Evaluation of the clinical decision model included diagnostic performance and feasibility of the
model. Primary outcome measures were correct diagnoses (SBI) and their related false posi-
tive/negative diagnoses by using the clinical decision model in routine practice. Secondly, we
measured process outcomes including length of stay (LOS) at the ED and items on diagnostics,
treatment and follow-up as defined below.
Statistical analysis
Power analysis. Previous research in the same setting showed that approximately 50% of
febrile children at the ED were submitted to diagnostic procedures (blood tests, urine-cultures
and chest-radiography).[31] To detect a reduction of unnecessary diagnostic tests from 50% to
35% (false positives) to improve our primary outcome of correct diagnosis, the intervention
and control group should include 180 children each (80% power; type-I error of 5%; 2-sided
Fig 1. Clinical decisionmodel.Clinical decision model with its predictors (above) and recommendations (below).
doi:10.1371/journal.pone.0127620.g001
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test). This number of patients also allows detecting a difference of 10 minutes patients’ ED
length of stay (30 minutes standard deviation (SD)). Adjusted for 10–15% dilution effect by
nurses managing both intervention and control patients during the same shift [32] and adjust-
ed for 10% not evaluable cases, the trial planned to include 500 children with fever.
Evaluation clinical decision model. We first assessed the performance of the clinical pre-
diction model for our trial population by evaluating discriminative ability according to the
area-under-the-receiver-operating-characteristic-curve (AUC) and calibration.[10] Predicted
risks of pneumonia and other SBI were compared with the observed proportions of pneumonia
and other SBI to assess calibration.[10, 33] Feasibility was measured by compliance of the
nurses to the recommendations of the clinical decision model.
SBI were defined according to a reference standard and included abnormal radiographic
findings and positive cultures from otherwise sterile body sites (urine, blood, spinal fluid) or
excluded by uneventful follow-up by telephone three days after ED discharge. A consensus di-
agnosis was made if the reference standard was inconclusive (by investigators EK, RGN, RO).
[34] [35] All final diagnoses were classified as either pneumonia, other SBI or no SBI. Outcome
measures were coded blinded for the allocated randomization arm.
Impact analysis. The impact of the decision model was analysed by intention to treat. We
evaluated the impact of the clinical decision model by measuring correct diagnoses (SBI) and
their related false positive/negative diagnoses,as our primary patient outcome, indicating effects
of using the intervention strategy irrespective of overruling or non-compliance by the physician
versus the usual care strategy. Primary patient outcomes of the decision model in intervention
and usual care were compared using Chi-square analysis. We defined false positives as children
without SBI incorrectly exposed to diagnostic tests and false negatives as children with SBI in-
correctly refrained from diagnostic tests. We presented sensitivity (children with pneumonia/
UTI and performance of chest-radiography/urine-culture), specificity (children without pneu-
monia/UTI and no performance of chest-radiography/urine-culture) and their related positive/
negative likelihood ratios of the complete model. In the control group exposure to testing was
based on judgment of the physician only; in the intervention group this was based on the recom-
mendation of the clinical decision model and physicians’ judgment. LOS at the ED was based
on the triage starting time and ED departure time as registered in the nursing record; Diagnostic
procedures included chest-radiography, urine-dipstick, full blood-count and cultures (blood,
urine and others). Treatment/follow-up included antibiotic prescriptions, hospitalization and
revisits. Comparisons of process outcomes were tested with Chi-square or Student’s t test analy-
sis, P-values were two-tailed. All analyses were performed with SPSS PASW statistics software
(version 20.0; Chicago, Illinois) and R statistical packages (version 2.14, Vienna, Austria).[36]
Results
Out of 1,769 eligible febrile children 836 children were excluded because of chronic co-
morbidity, emergent triage category, uncomplicated rhinitis/otitis or revisits within 7 days, re-
sulting in 933 eligible children. 439 evaluable children were included for analysis (Fig 2) with a
median age of 1.8 years (IQR 0.9–4.1), 57% were boys (n = 249), and the SBI prevalence was
13% (n = 55) including 33 children with pneumonia and 22 children with other SBI (Table 1).
Evaluation clinical decision model
The discriminative ability of the clinical decision model was 0.83 (95% CI 0.75–0.90) for pneu-
monia and 0.81 (95% CI 0.72–0.90) for other SBI. The clinical prediction model had good cali-
bration in the study population, except for the upper quintiles due to the limited number of
cases with pneumonia or other SBI (Fig 3). We also observed limited variability of the predicted
Impact Clinical Decision Model for Febrile Children in Emergency Care
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Fig 2. Flowchart patient selection and randomization. Flowchart patient selection and Randomization.
doi:10.1371/journal.pone.0127620.g002
Fig 3. Calibration plot for the risk of pneumonia (left) and other SBI (right). Calibration plot of the predicted risks of pneumonia and other SBI (x-axis)
and the observed frequencies of pneumonia and other SBI (with 95% CI, y-axis). The triangles represent the mean (predicted vs. observed) risk estimates of
pneumonia and other SBI by quintiles of predicted risk. The dashed diagonal line represents ideal calibration. The distribution of the predicted risks of
patients with pneumonia (n = 33) and other SBI (n = 22) and other patients (n = 406 and n = 417) is shown in the bottom of the graph, parallel to the x-axis.
doi:10.1371/journal.pone.0127620.g003
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risks (SD 0.06 for pneumonia and 0.08 for other SBI) with only 10% of the children (n = 44)
being categorized as high risk. Consequently, model recommendations were limited and the
majority of children rightly did not undergo diagnostics. 60% (18/30) of the children assigned
to high-risk for pneumonia did not have final diagnosis of pneumonia, for other SBI this was
71% (10/14). Five percent (21/409) of children assigned to low-risk for pneumonia had a final
diagnosis of pneumonia, for other SBI this was 4% (18/425). All children assigned to high-risk
categories with a final diagnosis of SBI received antibiotics (20/20) compared to 57% of high-
risk children without final diagnoses of SBI (13/23). Compliance to the recommendations of
the clinical decision model in the intervention arm by nurses was high; only three high-risk pa-
tients did not receive the recommended diagnostics for either pneumonia (n = 2) or other SBI
(n = 1) because of overruling by the physician. In 28 low-risk patients without clear other
focus, no urine-dipstick testing was done, leading to a compliance of 86% (188/219).
Primary patient outcome
In 60% (25/42) of all children allocated to the intervention group chest-radiography was done
but no pneumonia was diagnosed (false positives, Table 2). This percentage was not significant-
ly different from the 57% (16/28) false positives of the control group (p = 0.84). In 67% (12/18)
of all children in the intervention group urine-culture was collected but no UTI was diagnosed
(false positives), but did not differ from the control group (53%, 9/17) (p = 0.41). The clinical
decision model performed similarly between both study groups with regard to false negatives
(Table 2).
Secondary process outcomes
Median LOS did not differ for children in both the intervention as the control group (1h57min
vs. 1h54min, respectively) (Table 2). In the intervention group less full blood-count tests (14%
vs. 22%, p-value<0.05) and more urine-dipsticks were done correctly according to current
guidelines [26] (71% vs. 61%, p-value<0.05). The number of chest-radiographies and urine-
cultures were somewhat higher in the intervention group, although not significant. Overall
treatment with antibiotics did not substantially differ between both study groups, (23% in in-
tervention group vs. 27% in control group) (p = 0.30) (Table 2). Finally, no differences in hos-
pitalization or revisits were noted between both study groups.
Discussion
Main findings
This impact analysis showed good compliance to the decision model recommendations and its
good discriminative ability for detecting SBI was confirmed in febrile children presenting to
the ED. Unfortunately, we could not demonstrate improved assessment of correct diagnoses by
the intervention. Application of the clinical decision model resulted in a more standardized di-
agnostic approach towards the febrile child, with significantly less full blood-counts and more
rightfully performed urine-dipstick testing in the intervention group.
Comparison with other studies
This randomized controlled impact trial provides the methodological step after external valida-
tion of a developed decision model with good discriminative ability for predicting the presence
of pneumonia and other SBI.[10] As an essential step before proven clinical applicability, we
performed this impact analysis to test whether or not the decision model actually improved
clinical decisions, benefitted patient care or reduced costs.[10, 19–21]
Impact Clinical Decision Model for Febrile Children in Emergency Care
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Table 2. Patient and process outcome.
Intervention group Usual care group
(n = 219) (n = 220)
Patient outcome—pneumonia
False positive (no pneumonia/ chest-radiography performed) 25/42 (60%) 16/28 (57%)
Sensitivity to detect pneumonia 0.89 (0.69–0.97)$1 0.86 (0.60–0.96)$2
Positive likelihood ratio 7.16 (4.81–10.66) 11.0 (6.58–18.81)
False negative (pneumonia/no chest-radiography performed) 2/177 (1%) 2/192 (1%)
Specificity to detect pneumonia 0.88 (0.82–0.91)$3 0.92 (0.88–0.95)$4
Negative likelihood ratio 0.12 (0.03–0.45) 0.16 (0.04–0.56)
Patient outcome—other SBI
False positive (no UTI/ urine-culture performed) 12/18 (67%) 9/17 (53%)
Sensitivity to detect UTI 1.0 (0.61–1.0)$5 0.89 (0.57–0.98)$6
Positive likelihood ratio 17.7 (10.2–30.7) 20.8 (10.6–41.1)
False negative (UTI/ no urine-culture performed) 0/201 (0%) 1/203 (0.5%)
Specificity to detect UTI 0.94 (0.90–0.97)$7 0.96 (0.92–0.98)$8
Negative likelihood ratio - 0.12 (0.02–0.74)
Process outcomes
1. Patient consultation time
Time spent at the ED (hrs:min)a 1:57 (1:24–2:38) 1:54 (1:21–2:42)
2. Diagnostics
Chest-radiography 42 (19.2) 28 (12.7)
Urine-dipstick 156* (71.2) 133* (60.5)
Urine-culture 18 (8.2) 17 (7.7)
Full blood-count# 31* (14.2) 48* (21.8)
Blood culture 13 (5.9) 20 (9.1)
Other cultures~ 20 (9.1) 25 (11.4)
Overall± 124 (56.6) 138 (62.7)
3. Treatment
Antibiotics at the ED (iv) 9 (4.1) 14 (6.4)
Antibiotics at discharge (oral) 69 (31.5) 78 (35.5)
SBIreceiving antibiotics / SBItotal 25/27 (92.6) 26/28 (92.9)
no SBIreceiving antibiotics / no SBItotal 44/192 (22.9) 52/192 (27.1)
4. Follow-up
No 124 (56.6) 137 (62.3)
Hospitalization 26 (11.9) 23 (10.5)
Outpatient clinic 22 (10.0) 27 (12.3)
Telephone call 47 (21.5) 33 (15.0)
5. Safety netting
Revisit 47 (21.5) 45 (20.5)
Antibiotics after revisit 12 (5.5) 8 (3.6)
(Continued)
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From a literature review it is known that only a minority of new developed clinical predic-
tion models underwent broad validation and no model had undergone impact analysis.[18]
The results of our trial were comparable with a recent literature review or individual studies on
the effect of these models which showed effects on process outcomes, but only sparse effects on
patient outcomes, costs or efficiency.[37, 38] However, this review included only two predic-
tion rules applicable to pediatric emergency care.[31, 39]
Clinical and research implications
Although our study reports good compliance to and high accuracy of the clinical decision
model, positive impact on routine care was lacking. A number of reasons have been described
that explain why an accurate clinical prediction model may not result in improved patient care
and processes.[40–42] One important reason is that physicians’ intuitive estimation of proba-
bilities may be as good as, if not better than, the prediction model. This is reflected by high pos-
itive and negative likelihood ratios [8] in the detection of pneumonia/ UTI for both the
intervention as the usual care group (Table 2). Clinicians approach in febrile child management
is already on the safe side, as reflected by the absence of worse primary outcomes which was
part of our primary outcome. As in practice one would never accept increased false negative di-
agnoses, it can be considered that trials as ours can only have effects on secondary (process)
outcomes like diagnostic tests and treatment. Next, it can be argued that studying improved pa-
tient outcomes in febrile children is difficult anyway, with decreasing prevalence of the most se-
vere diagnoses as sepsis and meningitis.[43] Furthermore, this implementation trial was
conducted at a highly specialized and experienced university pediatric ED, with residents and
experienced supervising pediatricians. We expect that future use of the clinical decision model
in a more general setting with less specialized medical staff may lead to improved process
outcomes.
One major influence explaining the lack of impact on LOS was probably the availability of
CRP bedside-testing in both study groups. Previous research showed that CRP bedside-guided
Table 2. (Continued)
Intervention group Usual care group
(n = 219) (n = 220)
Hospitalization 7 (3.2) 5 (2.3)
SBI = serious bacterial infection.
UTI = urinary tract infection.
a Median (25–75 percentiles).
# including hemoglobin, leukocyte, thrombocyte and differential count.
~including feces culture, nasal swab, throat culture and cerebrospinal fluid (CSF) culture.
*Chi-square, p-value <0.05.
± Overall diagnostics minus urine-dipstick analysis.
$1 In 17 of 19 children with pneumonia chest-radiography was performed.
$2 In 12 of 14 children with pneumonia chest-radiography was performed.
$3 In 175 of 200 children without pneumonia no chest-radiography was performed.
$4 In 190 of 206 children without pneumonia no chest-radiography was performed.
$5 In 6 of 6 children with UTI a urine-culture was performed.
$6 In 8 of 9 children with UTI a urine-culture was performed.
$7 In 201 of 213 children without UTI no urine-culture was performed.
$8 In 202 of 211 children without UTI no urine-culture was performed.
doi:10.1371/journal.pone.0127620.t002
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decision making reduced the LOS at the pediatric ED by 19% (median LOS 148 minutes).[25]
The rationale for testing CRP in all children was already discussed before in the original paper.
[10] For this trial we wanted to test the effect of the decision model as a whole, rather than test-
ing the individual effect of CRP. Finally, we completed our impact trial with a cost-minimisa-
tion study (S1 File). Costs of our process outcomes (e.g. blood counts, urine analysis) were low
and no difference were found in e.g. hospitalization rate or costs of adverse events. As a conse-
quence, neither this impact analysis, nor a sensitivity analysis could demonstrate substantial
cost savings of using the clinical decision model compared with usual care management.
Compliance to the recommendations of the clinical decision model was good. However, we
did not include 379 children for unknown reasons, which may suggest some feasibility prob-
lems of the decision model itself, but also reflects the difficulties of performing a randomized
controlled trial (with the need of informed consent) in emergency care. As we did not observe
significant differences on median age (1.9 (IQR 2.0–3.0) vs. 1.8 (IQR 2.0–3.0)), gender (55.7%
males vs. 56.7% males) and prevalence of SBI (14.2% vs. 12.5%), when we compared non-in-
cluded with included patients, we feel that this most likely did not affect generalizability of our
results. Another measure of feasibility could be whether the model variables were completed
directly after the patient’s triage. This was not the case for all patients, as some were seen by a
physician directly during the triage process of the nurse.[5, 23] In more densely crowded ED
settings that require triage systems to truly prioritize physicians’ tasks, higher efficiency due to
the implementation of the decision model can be expected.
Strengths and limitations
The main strength of this study is its randomized design to evaluate the last step required for
translating prediction research into clinical practice. Second, as we modelled children’s age in a
linear piecewise manner,[10] we accounted for the differentiated risks and the uniqueness of
signs and symptoms of children in the broad included age group. A subgroup analysis on chil-
dren aged36 months (n = 287; 65%), who are considered the primary focus in many diagnos-
tic fever studies [44], had similar conclusions. Next, we created optimal conditions for the
implementation before we started our impact trial.[45] First, we ensured the compliance of the
nurses to the computerized patient triage system at our ED was already high (90% compliance
and 97% adherence to the MTS advice).[46] Second, there was an electronic patient record for
nurse’s evaluation and, the clinical decision model was implemented in the routine workflow at
the pediatric ED. Thirdly, involvement of the nurses during the process of tailoring the format
of decision models to the local circumstances resulted in willingness to adopt the system in rou-
tine care.[47] Finally, we incorporated a structured follow-up by telephone for ruling-out the
possibility of missed and clinically relevant SBI diagnoses in children not fulfilling reference
standard criteria. This helps us to reduce verification bias, and is recommended as a valid
proxy for missing reference tests [48].
Our study has some limitations. First, reference tests were ordered based on the recommen-
dations of the clinical decision model or at the physician’s discretion. However, to reduce veri-
fication bias we used a standardized follow-up period to ensure no clinically relevant SBI were
missed in children who did not have chest-radiography or specimens bacterial culture.[48, 49]
In addition, as antibiotic prescription is relatively low in our study (around 30%), limiting the
number of children with true SBI who had no reference standards done by pre-emptive antibi-
otics use, we can assume that associated false negative diagnoses were low. Second, some inter-
observer variability might have influenced the validity of the clinical decision model.[50] As
the discriminative ability of the model was good in this study, as in previous settings [10] and
the model included mainly vital (relative objective) signs, this limitation has probably not
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influenced our results negatively. Third, although the clinical decision model was integrated in
the nurses’ regular work-flow as stand-alone software, optimal implementation would have
been a fully integrated system in the computer-based hospital information system including
automatic pop-up screens and reminders. Fourth, from the perspective to focus on febrile chil-
dren with the largest diagnostic uncertainty, selection criteria differed slightly from the original
population in which the model was derived. As the validity was preserved in this new (random-
ized) population, selection of slightly different patients won’t have affected results, but may
have some consequences for generalization of results to other settings.
Finally, our clinical decision model advised on performing chest-radiographies which is in
contrast with recent advice of the British Thoracic Society [51] on limited use of chest-radiog-
raphies in suspected childhood pneumonia. As the model fairly classifies high/low risk of SBI,
we expect it can validly guide decisions on appropriate treatment as well. This might be sup-
ported by the lower unnecessary antibiotic prescriptions in the intervention group. Therefore,
future recommendations of the clinical decision model may preferably focus on impact on
therapeutic management like antibiotic prescription.
Conclusion
This impact analysis translates a validated clinical prediction model for febrile children into
clinical practice. Although we observed well implementation, no substantial impact on patient
outcome was perceived. Further evaluation may focus on impact in other settings with greater
variability in experience in the assessment of the febrile child, in patient numbers, and in preva-
lence of outcome measures, or may include guidance on therapeutic management.
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